After the first description of fatty pancreas in 1933, the effects of pancreatic steatosis have
been poorly investigated, compared with that of the liver. However, the interest of research is …

Obesity is a growing problem worldwide and disorders associated with excess body fat
including the metabolic syndrome, type 2 diabetes mellitus (T2DM), cardiovascular disease …

Fatty pancreas is a newly recognized condition which is poorly investigated until today as
compared to nonalcoholic fatty liver disease. It is characterized by pancreatic fat …

Pancreatic steatosis is an emerging clinical entity whose pathophysiology, natural history,
and long-term complications are poorly characterized in the current literature …

Obesity is a growing health burden worldwide, increasing the risk for several diseases
featuring the metabolic syndrome–type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty …

Nonalcoholic fatty pancreas disease (NAFPD) is an emerging disease that has gained an
increasing amount of attention in recent years. It describes fat accumulation in the pancreas …

Aim The purpose of this study was to clarify whether fatty pancreas might lead to impaired
pancreatic endocrine or exocrine function. Material and methods The study involved 109 …

Materials and Methods Forty-three patients with PS determined by 3 tesla magnetic
resonance imaging (MRI) and 48 patients without PS were included in this study. Patients …

В статье приводится обзор современных взглядов на поражение печени, желчного
пузыря и поджелудочной железы у пациентов с избыточной массой тела и ожирением …

Obesity will lead to millions of deaths each year and pancreatic steatosis may be the key
intermediate entity that leads to obesity-related complications. Enhancing our understanding …